Palisade Bio Inc.
PALI | NASDAQ
$1.63
-$0.06 (-3.55%)
Sep 22, 2026, 2:42 PM ET · Market open
Market Data
Market Cap $293.35M
Enterprise Value $168.18M
Beta 1.55
Average Volume 2.8M
Shares Outstanding (Diluted) 211.38M
Shares Change YoY 4306.37%
Institutional Ownership 71.30%
Exchange NASDAQ
ISIN US6963894026
Price Performance
Price Change 1M -19.1%
Price Change 3M -12.9%
Price Change 6M -15.5%
Price Change YTD -32.4%
Price Change 1Y 166.2%
Price Change 3Y -79.4%
Price Change 5Y -99.9%
1M CAGR (ann.) -19.9%
1Y CAGR (ann.) 182.6%
5Y CAGR (ann.) -76.1%
All-Time CAGR -51.1%
Valuation
PE Ratio -3.19
Forward PE N/A
PEG Ratio -0.01
Forward PEG -0.13
PS Ratio 586.70
Forward PS 6.10
PB Ratio 2.41
P/FCF Ratio -16.13
P/Adj. FCF Ratio -9.44
P/OCF Ratio -18.78
EV/Sales 336.36
EV/EBIT -5.06
EV/EBITDA -5.06
EV/FCF -9.25
Earnings Yield -31.4%
FCF Yield -6.2%
Adj. FCF Yield -10.6%
Financial Health
Net Cash $125.17M
Total Debt $0
Cash & Short-Term Investments $125.17M
Total Assets $127.32M
Current Ratio 24.26
Quick Ratio 24.26
Debt / Equity Ratio 0.00
Debt / EBITDA -0.00
Debt / FCF -0.00
OCF / Debt N/A
Interest Coverage -5,891.50
Altman Z-Score 30.01
Piotroski F-Score 4
Margins & Profitability
Gross Profit Margin 100.0%
Operating Profit Margin -7069.8%
EBITDA Margin -6643.8%
Net Profit Margin -6388.2%
FCF Margin -3638.0%
Adj. FCF Margin -6217.8%
SBC / Revenue 2579.8%
SBC Impact (per share) -70.9%
Returns
Return on Assets -25.1%
Return on Equity -33.5%
Return on Invested Capital -29.0%
Return on Capital Employed -29.0%
Return on Tangible Assets -25.1%
Historical Growth (CAGR)
Revenue CAGR 3Y 26.0%
Revenue CAGR 5Y 50.0%
Revenue CAGR 10Y 47.9%
EPS CAGR 3Y 113.7%
EPS CAGR 5Y 21.0%
EPS CAGR 10Y 8.0%
FCF CAGR 3Y -22.9%
FCF CAGR 5Y -6.7%
FCF CAGR 10Y -3.4%
Analyst Forecasts
Analyst Rating Buy
Analyst Count 3
EPS Growth Next 3Y 10.1%
Revenue Growth Next 3Y 646.1%
Earnings Date Nov 8, 2026
EPS Estimate (next Q) -$0.06
EPS Growth Est (next Q) -84.2%
Revenue Est (next Q) $465.3K
Revenue Growth Est (next Q) N/A
Fair Value Estimates
Graham Number N/A
Graham Upside N/A
Lynch Fair Value N/A
Lynch Upside N/A
Price Target $4.50
Price Target Upside 166.3%
Cash Flow
Operating Cash Flow $-18.19M
Free Cash Flow $-18.19M
Adj. Free Cash Flow $-31.09M
FCF Per Share -$0.09
OCF Per Share -$0.09
OCF/S Ratio -3638.0%
Income Statement
Revenue $500K
Gross Profit $500K
Operating Income $-35.35M
EBITDA $-33.22M
Net Income $-31.94M
EPS (Diluted) -$0.53
Revenue / Employee $35.71K
Profit / Employee $-2.28M
Employees 14
Add to Watchlist
Select watchlists to add or remove PALI